Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could your own fat cells heal diabetic nerve damage?

NCT ID NCT07553468

Disease control Sponsor: Michael H Carstens Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This small study tested whether injecting a person's own fat-derived cells (called stromal vascular fraction) into the foot could help heal diabetic nerve damage and foot ulcers. Eight adults with diabetic peripheral neuropathy received injections around the wound and along nerve pathways. Researchers measured ulcer healing and changes in touch and vibration sensation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
fat-derived stem cells (stromal vascular fraction)
What this could lead to
If it works, this could point toward a treatment that heals diabetic foot ulcers and restores some feeling in the feet.
What could go wrong
This was a very small study with only 8 people and no comparison group, so results may not apply widely. The treatment involves injections and surgery, which carry infection and pain risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

8 people

The number who actually took part.

Started

Dec 2024

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Clinically stable diabetes * Presence of DPN as documented reductions in sensory perception threshold (SPT) and/or vibration perception threshold below protective levels * Capacity to understand and provide informed consent. Exclusion Criteria: * Presence of a disease prohibitive of surgical intervention * Smoking and/or substance abuse within 3 months of the onset of the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic foot are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Diabetic Foot diabetic neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetic foot Diabetic peripheral neuropathy

Contacts and locations

Locations

  • Hospital Escuela Oscar Danilo Rosales Argüello

    León, León Department, 21000, Nicaragua

More trials for these conditions

Other studies related to the condition(s) this trial covers.